A detailed history of Employees Retirement System Of Texas transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Employees Retirement System Of Texas holds 661 shares of HALO stock, worth $42,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares
661
Holding current value
$42,720
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$47.91 - $70.14 $31,668 - $46,362
661 New
661 $34,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $9B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.